CaseTrail

Association for Molecular Pathology v. Myriad Genetics, Inc.

569 U.S. 576 · Decided June 13, 2013 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

Association for Molecular Pathology v. Myriad Genetics, Inc. was decided on June 13, 2013 unanimously (9–0). The Court affirmed the lower court's decision in part, reversed or vacated it in part, and remanded the case. Justice Clarence Thomas wrote the opinion of the Court. SCDB classifies its main issue as “Statutory construction of criminal laws, financial crimes” in the Criminal Procedure area.

Read the opinion

Case details

Citations
569 U.S. 576 · 133 S. Ct. 2107 · 186 L. Ed. 2d 124 · 2013 U.S. LEXIS 4540
Docket number
12-398
Decided
June 13, 2013
Argued
April 15, 2013
Court era
Roberts Court
Decision type
Opinion of the Court (orally argued)
Disposition
Affirmed and reversed (or vacated) in part and remanded
Outcome for petitioner
The petitioning party received a favorable disposition
Vote
9–0 (unanimous)
Majority opinion
Clarence Thomas
Opinion assigned by
John G. Roberts Jr.
How the case arrived
Certiorari
Legal provision
35-101
Type of law
Infrequently litigated statute
Decision direction (SCDB)
Conservative what this means

How the Justices voted

Full case caption

Association for Molecular Pathology, et Al., Petitioners v. Myriad Genetics, Inc., et al.

SCDB identifiers: case 2012-059, docket 2012-059-01.

Other cases on “Statutory construction of criminal laws, financial crimes”

See all

Cases on the same legal provision: 35-101

Same Term, same area (Criminal Procedure)

See all

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error